Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Short-Term Debt issuances (2017 - 2020)

Marimed (MRMD) has disclosed Short-Term Debt issuances for 4 consecutive years, with -$158301.0 as the latest value for Q3 2020.

  • Quarterly Short-Term Debt issuances fell 146.76% to -$158301.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $817295.0 through Sep 2020, up 592.91% year-over-year, with the annual reading at $1.2 million for FY2019, 641.92% up from the prior year.
  • Short-Term Debt issuances for Q3 2020 was -$158301.0 at Marimed, down from $177143.0 in the prior quarter.
  • The five-year high for Short-Term Debt issuances was $3.2 million in Q3 2017, with the low at -$3.4 million in Q4 2017.
  • Average Short-Term Debt issuances over 4 years is $49325.4, with a median of -$38745.5 recorded in 2018.
  • Peak annual rise in Short-Term Debt issuances hit 4943.6% in 2019, while the deepest fall reached 3677.85% in 2019.
  • Over 4 years, Short-Term Debt issuances stood at -$3.4 million in 2017, then soared by 99.37% to -$21451.0 in 2018, then surged by 4943.6% to $1.0 million in 2019, then tumbled by 115.24% to -$158301.0 in 2020.
  • According to Business Quant data, Short-Term Debt issuances over the past three periods came in at -$158301.0, $177143.0, and -$240547.0 for Q3 2020, Q2 2020, and Q1 2020 respectively.